Business Segments Getinge AB Deutsche Boerse AG
Stocks
GTN
SE0000202624
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Tradegate
11:42:26 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 22.15 EUR | +0.77% |
|
-0.45% | +9.89% |
| 08-25 | Getinge's profit consensus raised after the report, price target up 7.5 percent | FW |
| 08-24 | Länsförsäkringar Small Cap Sweden Vision rose 2.55% in July, increased stakes in Mips and Addnode | FW |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Therapeutic Devices | ||||||||||
Acute Care Therapies | 15.53B | 15.28B | 16.53B | 17.95B | 18.68B | |||||
Total Assets | 28.91B | 32.61B | 32.92B | 39.77B | 35.1B | |||||
CAPEX | -708M | -855M | - | - | - | |||||
Gross Profit | 9.6B | 9.17B | 9.66B | 10.42B | 10.9B | |||||
EBITDA | 5.27B | 4.27B | 4.02B | 4.47B | 4.62B | |||||
D&A | 1.06B | 1.23B | 1.21B | 1.42B | 853M | |||||
Operating Income | 4.44B | 2.89B | 3.22B | 2.06B | 3.02B | |||||
Medical Equipment | ||||||||||
Surgical Workflows (Excluding Life Science) | 7.96B | 8.98B | 10.97B | 12.26B | 11.8B | |||||
Total Assets | 7.47B | 9.28B | 12.72B | 15.17B | 12.91B | |||||
CAPEX | -165M | -212M | - | - | - | |||||
Gross Profit | 3.3B | 3.64B | 4.35B | 5.18B | 5.03B | |||||
EBITDA | 949M | 1.13B | 1.3B | 1.73B | 1.7B | |||||
D&A | 578M | 608M | 649M | 742M | 619M | |||||
Operating Income | 390M | 480M | 675M | 703M | 773M | |||||
Surgical Workflows | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Patient & Post-Acute Care | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Life Science | 3.56B | 4.03B | 4.32B | 4.55B | 4.5B | |||||
Total Assets | 2.88B | 3.41B | 4.16B | 5.2B | 4.27B | |||||
CAPEX | -57M | -69M | - | - | - | |||||
Gross Profit | 1.49B | 1.55B | 1.53B | 1.81B | 1.68B | |||||
EBITDA | 870M | 801M | 620M | 818M | 712M | |||||
D&A | 166M | 176M | 222M | 257M | 222M | |||||
Operating Income | 729M | 600M | 395M | 526M | 470M | |||||
CAPEX | - | - | - | - | - | |||||
Operating Income | -351M | -343M | -549M | -440M | -474M | |||||
Total Assets | 5.29B | 6.72B | 3.79B | 3.78B | 4.23B | |||||
D&A | 13M | 10M | 9M | 8M | - |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Usa | - | - | 11.7B | 13.93B | 14.16B | |||||
Total Assets | - | - | 23.11B | 32.23B | 26.51B | |||||
Europe, Middle East and Africa (Excl. Sweden) | 9.68B | 9.58B | 11.11B | 11.56B | 11.69B | |||||
Total Assets | 8.69B | 9.72B | 9.56B | 9.51B | 8.91B | |||||
Asia and Pacific (APAC) | 6.63B | 6.7B | 6.94B | 7.06B | 6.94B | |||||
Total Assets | 860M | 867M | 761M | 791M | 681M | |||||
Americas (Excl. USA) | - | - | 1.45B | 1.59B | 1.53B | |||||
Total Assets | - | - | 107M | 100M | 85M | |||||
Sweden | 492M | 549M | 632M | 617M | 648M | |||||
Total Assets | 2.11B | 2.34B | 2.34B | 2.31B | 2.27B | |||||
Americas | 10.25B | 11.47B | - | - | - | |||||
Total Assets | 16.6B | 18.96B | - | - | - |
- Stock Market
- Stocks
- GETI B Stock
- GTN Stock
- Financials Getinge AB
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
















